Literature DB >> 23196783

Glucocorticoid receptor and molecular chaperones in the pathogenesis of adrenal incidentalomas: potential role of reduced sensitivity to glucocorticoids.

Svetozar S Damjanovic1, Jadranka A Antic, Bojana B Ilic, Bojana Beleslin Cokic, Miomira Ivovic, Sanja I Ognjanovic, Tatjana V Isailovic, Bojana M Popovic, Ivana B Bozic, Svetislav Tatic, Gordana Matic, Vera N Todorovic, Ivan Paunovic.   

Abstract

Glucocorticoid (GC) sensitivity depends on glucocorticoid receptor (GR) and heat shock proteins (Hsps). We investigated whether common GR genes (ER22/23EK, N363S, Bcl I, and 9β) and adrenocorticotropin receptor promoter polymorphisms influence susceptibility for unilateral adrenal incidentaloma (AI), plus GR and Hsp expression in tumorous (n = 19), peritumorous (n = 13) and normal adrenocortical (n = 11) tissues. Patients (n = 112), population-matched controls (n = 100) and tumor tissues (n = 32) were genotyped for these polymorphisms. Postdexamethasone serum cortisol was higher in patients (p < 0.001). GR gene variants, larger allele of Bcl I (odds ratio [OR] 2.9; 95% confidence interval [CI] 1.7-5.1; p < 0.001] and minor allele of 9β (OR 3.0; 95% CI 1.6-5.7; p < 0.001) were independent predictors of AI. In patients, the first allele is linked with larger tumors (p = 0.002) and the latter with higher postdexamethasone cortisol levels (p = 0.025). Both allele carriers had lesser waist circumference (p = 0.02), similar adrenocorticotropin and higher basal (p = 0.024) and postdexamethasone cortisol concentrations (p < 0.001). Tumorous and constitutional genotypes were similar. GR-D is the major receptor isoform in normal adrenal cortex by Western blotting. Loss of other receptor isoforms, decrease in immunostaining for GR (p < 0.0001), underexpression of chaperones (p ≤ 0.01) and the presence of inducible Hsp70 were found in adenomas. In conclusion, GR gene variants, C allele of Bcl I and minor allele of 9β, are associated with AIs. Their concurrent presence in patients reduces GC sensitivity. Normal adrenal cortex preferentially expresses GR-D. In adenomas, the lack of other GR isoforms and underexpression of heat shock proteins perhaps permanently impair GC signaling, which could promote dysregulated cortisol production and tumor growth. The innate GC sensitivity probably modifies these effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23196783      PMCID: PMC3563706          DOI: 10.2119/molmed.2012.00261

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  55 in total

Review 1.  Intracellular glucocorticoid signaling: a formerly simple system turns stochastic.

Authors:  George P Chrousos; Tomoshige Kino
Journal:  Sci STKE       Date:  2005-10-04

2.  Fetal and adult sheep adrenal cortical cells contain glucocorticoid receptors.

Authors:  K Yang; J R Challis
Journal:  Biochem Biophys Res Commun       Date:  1989-07-31       Impact factor: 3.575

3.  Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

Authors:  Nick Z Lu; John A Cidlowski
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

4.  Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex.

Authors:  Brian M Gummow; Joshua O Scheys; Victoria R Cancelli; Gary D Hammer
Journal:  Mol Endocrinol       Date:  2006-07-20

5.  Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women.

Authors:  Akheel A Syed; Julie A E Irving; Christopher P F Redfern; Andrew G Hall; Nigel C Unwin; Martin White; Raj S Bhopal; Jolanta U Weaver
Journal:  Obesity (Silver Spring)       Date:  2006-05       Impact factor: 5.002

6.  Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland.

Authors:  D S Loose; Y S Do; T L Chen; D Feldman
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

7.  Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors.

Authors:  W Liu; A G Hillmann; J M Harmon
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.

Authors:  S Tsagarakis; P Kokkoris; C Roboti; C Malagari; J Kaskarelis; V Vlassopoulou; C Alevizaki; N Thalassinos
Journal:  Clin Endocrinol (Oxf)       Date:  1998-05       Impact factor: 3.478

9.  The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients.

Authors:  Anna Maria Di Blasio; Elisabeth F C van Rossum; Sabrina Maestrini; Maria Elisa Berselli; Mariantonella Tagliaferri; Francesca Podestà; Jan W Koper; Antonio Liuzzi; Steven W J Lamberts
Journal:  Clin Endocrinol (Oxf)       Date:  2003-07       Impact factor: 3.478

10.  Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.

Authors:  G P Bernini; A Moretti; P Viacava; A G Bonadio; P Iacconi; P Miccoli; A Salvetti
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more
  7 in total

Review 1.  MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.

Authors:  Sara De Iudicibus; Marianna Lucafò; Stefano Martelossi; Chiara Pierobon; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

2.  Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?

Authors:  A B Moraes; E M R Cavalari; M P de Paula; M Arruda; D S C Curi; R A Leitão; L M C de Mendonça; M L F Farias; M Madeira; L Vieira Neto
Journal:  J Endocrinol Invest       Date:  2018-11-21       Impact factor: 4.256

3.  Characterization and gonadal hormone regulation of a sexually dimorphic corticotropin-releasing factor receptor 1 cell group.

Authors:  Zachary J Rosinger; Jason S Jacobskind; Nicole Bulanchuk; Margaret Malone; Danielle Fico; Nicholas J Justice; Damian G Zuloaga
Journal:  J Comp Neurol       Date:  2018-12-24       Impact factor: 3.215

4.  Carotid Intima-Media Thickness as the Cardiometabolic Risk Indicator in Patients with Nonfunctional Adrenal Mass and Metabolic Syndrome Screening.

Authors:  Mehtap Evran; Gamze Akkuş; İlayda Berk Bozdoğan; Mustafa Gök; Ali Deniz; Murat Sert; Tamer Tetiker
Journal:  Med Sci Monit       Date:  2016-03-26

5.  Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas.

Authors:  Giuseppe Reimondo; Iacopo Chiodini; Soraya Puglisi; Anna Pia; Valentina Morelli; Darko Kastelan; Salvatore Cannavo; Paola Berchialla; Daniela Giachino; Paola Perotti; Alessandra Cuccurullo; Piero Paccotti; Paolo Beck-Peccoz; Mario De Marchi; Massimo Terzolo
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

6.  The Occurrence of Subclinical Hypercortisolism and Osteoporosis in Patients with Incidentally Discovered Unilateral and Bilateral Adrenal Tumors.

Authors:  Sanja Ognjanović; Djuro Macut; Milan Petakov; Valentina Elezović Kovačević; Tatjana Isailović; Ivana Bozić Antić; Dušan Ilić; Bojana Popović; Tamara Bogavac; Tatjana Pekmezović; Svetozar Damjanović
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

Review 7.  Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside.

Authors:  Vittoria Favero; Arianna Cremaschi; Chiara Parazzoli; Alberto Falchetti; Agostino Gaudio; Luigi Gennari; Alfredo Scillitani; Fabio Vescini; Valentina Morelli; Carmen Aresta; Iacopo Chiodini
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.